In vivo miR-449b mimic-based nanotherapy suppresses growth and progression of triple-negative breast cancer

被引：1
|
作者：
Kara, Goknur
Ozpolat, Bulent
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3786
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Ultrasound-Enhanced Mitochondrial Targeting for Synergistic Mitoxantrone-Based Nanotherapy in Triple-Negative Breast Cancer
    Zhang, Hongjie
    Geng, Rui
    Zheng, Benyan
    Wang, Jing
    Hu, Yuan
    Ma, Xiaopeng
    ACS APPLIED NANO MATERIALS, 2025, 8 (05) : 2382 - 2392
  • [22] Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth
    Shim, So Hee
    Sur, Subhayan
    Steele, Robert
    Albert, Carolyn J.
    Huang, Chunfa
    Ford, David A.
    Ray, Ratna B.
    MOLECULAR CARCINOGENESIS, 2018, 57 (11) : 1599 - 1607
  • [23] Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
    Rui Han
    Hongxing Yang
    Changquan Ling
    Lingeng Lu
    Cancer Cell International, 22
  • [24] Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
    Cui, Liyang
    Gouw, Arvin M.
    LaGory, Edward L.
    Guo, Shenghao
    Attarwala, Nabeel
    Tang, Yao
    Qi, Ji
    Chen, Yun-Sheng
    Gao, Zhou
    Casey, Kerriann M.
    Bazhin, Arkadiy A.
    Chen, Min
    Hu, Leeann
    Xie, Jinghang
    Fang, Mingxi
    Zhang, Cissy
    Zhu, Qihua
    Wang, Zhiyuan
    Giaccia, Amato J.
    Gambhir, Sanjiv Sam
    Zhu, Weiping
    Felsher, Dean W.
    Pegram, Mark D.
    Goun, Elena A.
    Le, Anne
    Rao, Jianghong
    NATURE BIOTECHNOLOGY, 2021, 39 (03) : 357 - 367
  • [25] Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
    Liyang Cui
    Arvin M. Gouw
    Edward L. LaGory
    Shenghao Guo
    Nabeel Attarwala
    Yao Tang
    Ji Qi
    Yun-Sheng Chen
    Zhou Gao
    Kerriann M. Casey
    Arkadiy A. Bazhin
    Min Chen
    Leeann Hu
    Jinghang Xie
    Mingxi Fang
    Cissy Zhang
    Qihua Zhu
    Zhiyuan Wang
    Amato J. Giaccia
    Sanjiv Sam Gambhir
    Weiping Zhu
    Dean W. Felsher
    Mark D. Pegram
    Elena A. Goun
    Anne Le
    Jianghong Rao
    Nature Biotechnology, 2021, 39 : 357 - 367
  • [26] Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
    Han, Rui
    Yang, Hongxing
    Ling, Changquan
    Lu, Lingeng
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [27] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [28] ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA
    Humphries, Brock
    Wang, Zhishan
    Li, Yunfei
    Jhan, Jing-Ru
    Jiang, Yiguo
    Yang, Chengfeng
    CANCER RESEARCH, 2017, 77 (15) : 4051 - 4064
  • [29] LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
    Aini, Shataer
    Bolati, Shayiti
    Ding, Wei
    Liu, Siyin
    Su, Pengcheng
    Aili, Saiding
    Naman, Yimin
    Xuekelaiti, Kuerban
    BIOENGINEERED, 2022, 13 (05) : 11430 - 11439
  • [30] MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
    Marek Svoboda
    Jiri Sana
    Martina Redova
    Jiri Navratil
    Marketa Palacova
    Pavel Fabian
    Ondrej Slaby
    Rostislav Vyzula
    Diagnostic Pathology, 7
12345